Savings through generic drug usage in the U.S. 2008-2017
Savings through generic drug usage in the United States from 2008 to 2017 (in billion U.S. dollars)
This statistic depicts savings through generic drug usage in the United States from 2008 to 2017. In 2017, the healthcare system in the United States saved some 265 billion U.S. dollars via the usage of generic drugs.
Savings through generic drug usage in the United States from 2008 to 2017 (in billion U.S. dollars)
Source
More information
Statistics on "Generics and biosimilars"
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Medicaid program savings through generic drug usage by U.S. state 2015
- Medicare savings through generic drug usage in the U.S. by state 2015
- Top generic entry drug savings in Canada by public drug plan 2012/2013
- Share of generic drugs in the pharmaceutical market in France 2016
- Generic substitution savings in France 2007-2014
- Generic market share value change worldwide 2006 vs. 2016, by region
- Generic market share change in unit volume worldwide 2006 vs. 2016, by region
- Generic share of dispensed prescriptions by formulation U.S. 2012 vs. 2017
- Share of top generic purchasing operations in U.S. 2017
- Spending on dispensed total vs. generic prescriptions in the U.S. 2017
- Adjusted and unadjusted generic prescription growth in U.S. 2013-2017
- Generic drug savings forecast for Canada 2015-2017
- Generic drug cost change for Canada 2016-2018
- Annual growth of the global generic market 2009-2015 by region
- Price difference of a patented drug vs. its generic in selected countries 2010
- Italy: household savings as share of disposable income 2000-2017
- Gross savings in Bangladesh 2005-2017
- Value of private saving and term deposits in the Arab region 2016-2017
- Gross savings as a share of GDP in Cambodia 2005-2017
- Financial resources in case of difficulties concerning the budget in France 2016
Statistics on "Generics and biosimilars"
Related topics
About Statista
